Cite
Heterobivalent Dual-Target Peptide for Integrin-α v β 3 and Neuropeptide Y Receptors on Breast Tumor.
MLA
Ferreira, Aryel H., et al. “Heterobivalent Dual-Target Peptide for Integrin-α v β 3 and Neuropeptide Y Receptors on Breast Tumor.” Pharmaceuticals (14248247), vol. 17, no. 10, Oct. 2024, p. 1328. EBSCOhost, https://doi.org/10.3390/ph17101328.
APA
Ferreira, A. H., Real, C. C., & Malafaia, O. (2024). Heterobivalent Dual-Target Peptide for Integrin-α v β 3 and Neuropeptide Y Receptors on Breast Tumor. Pharmaceuticals (14248247), 17(10), 1328. https://doi.org/10.3390/ph17101328
Chicago
Ferreira, Aryel H., Caroline C. Real, and Osvaldo Malafaia. 2024. “Heterobivalent Dual-Target Peptide for Integrin-α v β 3 and Neuropeptide Y Receptors on Breast Tumor.” Pharmaceuticals (14248247) 17 (10): 1328. doi:10.3390/ph17101328.